Dioxin exposure of human CD34+ hemopoietic cells induces gene expression modulation that recapitulates its in vivo clinical and biological effects.

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) has a large number of biological effects, including skin, cardiovascular, neurologic diseases, diabetes, infertility, cancers and immunotoxicity. We analysed the in vitro TCDD effects on human CD34+ cells and tested the gene expression modulation by means of microarray analyses before and after TCDD exposure. We identified 257 differentially modulated probe sets, identifying 221 well characterized genes. A large part of these resulted associated to cell adhesion and/or angiogenesis and to transcription regulation. Synaptic transmission and visual perception functions, with the particular involvement of the GABAergic pathway were also significantly modulated. Numerous transcripts involved in cell cycle or cell proliferation, immune response, signal transduction, ion channel activity or calcium ion binding, tissue development and differentiation, female or male fertility or in several metabolic pathways were also affected after dioxin exposure. The transcriptional profile induced by TCDD treatment on human CD34+ cells strikingly reproduces the clinical and biological effects observed in individuals exposed to dioxin and in biological experimental systems. Our data support a role of dioxin in the neoplastic transformation of hemopoietic stem cells and in immune modulation processes after in vivo exposure, as indicated by the epidemiologic data in dioxin accidentally exposed populations, providing a molecular basis for it. In addition, TCDD alters genes associated to glucidic and lipidic metabolisms, to GABAergic transmission or involved in male and female fertility, thus providing a possible explanation of the diabetogenic, dyslipidemic, neurologic and fertility effects induced by TCDD in vivo exposure.

[1]  Andrea S. Llera,et al.  The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host , 2008, Cancer and Metastasis Reviews.

[2]  M. Sweeney,et al.  Human health effects after exposure to 2,3,7,8-TCDD , 2000, Food additives and contaminants.

[3]  F. Petraglia,et al.  Corticotropin-releasing hormone, its binding protein and receptors in human cervical tissue at preterm and term labor in comparison to non-pregnant state , 2006, Reproductive biology and endocrinology : RB&E.

[4]  S. Petersen,et al.  The aryl hydrocarbon receptor pathway and sexual differentiation of neuroendocrine functions. , 2006, Endocrinology.

[5]  J. Preiß,et al.  Adverse Health Effects in Humans Exposed to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) , 2006, Reviews on environmental health.

[6]  W. Foster,et al.  The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on corticotrophin-releasing hormone, arginine vasopressin, and pro-opiomelanocortin mRNA levels in the hypothalamus of the cynomolgus monkey. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  R. Pohjanvirta,et al.  Remarkable residual alterations in responses to feeding regulatory challenges in Han/Wistar rats after recovery from the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). , 1990, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[8]  Carlo Zocchetti,et al.  Short- and long-term morbidity and mortality in the population exposed to dioxin after the "Seveso accident". , 2003, Industrial health.

[9]  D. Carrell,et al.  Protamine levels vary between individual sperm cells of infertile human males and correlate with viability and DNA integrity. , 2006, Journal of andrology.

[10]  T. Kume.  Foxc2 transcription factor: a newly described regulator of angiogenesis. , 2008, Trends in cardiovascular medicine.

[11]  M. Ogawa,et al.  Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: Involvement of regulation of LIF and its receptor expression. , 2007, International journal of oncology.

[12]  J. Michalek,et al.  Molecular Epidemiologic Evidence for Diabetogenic Effects of Dioxin Exposure in U.S. Air Force Veterans of the Vietnam War , 2006, Environmental health perspectives.

[13]  C. Baussan,et al.  Hereditary fructose intolerance: frequency and spectrum mutations of the aldolase B gene in a large patients cohort from France--identification of eight new mutations. , 2008, Molecular genetics and metabolism.

[14]  F. Holsboer.  Corticotropin-releasing hormone modulators and depression. , 2003, Current opinion in investigational drugs.

[15]  M. Walker,et al.  Inhibition of neovascularization by environmental agents , 2007, Cardiovascular Toxicology.

[16]  N. Robakis,et al.  Novel human glutamate dehydrogenase expressed in neural and testicular tissues and encoded by an X-linked intronless gene. , 1994, The Journal of biological chemistry.

[17]  J. Flaws,et al.  In utero effects of chemicals on reproductive tissues in females. , 2004, Toxicology and applied pharmacology.

[18]  C. Pallister,et al.  Stem Cell Factor: Biology and Relevance to Clinical Practice , 2001, Acta Haematologica.

[19]  Bryan D. Thompson,et al.  2,3,7,8-Tetracholorodibenzo-p-dioxin exposure disrupts granule neuron precursor maturation in the developing mouse cerebellum. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  M. Chiriva-Internati,et al.  Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies. , 2003, Blood.

[21]  D. Srivastava,et al.  The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. , 2000, The Journal of clinical investigation.

[22]  D. Neal,et al.  MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion , 2003, Oncogene.

[23]  M. Walker,et al.  In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effects on fetal and adult cardiac gene expression and adult cardiac and renal morphology. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  Maria Teresa Landi,et al.  Immunologic effects of dioxin: new results from Seveso and comparison with other studies. , 2002, Environmental health perspectives.

[25]  J. Preiß,et al.  Lipid metabolism and neuropsychological follow-up study of workers exposed to 2,3,7,8- tetrachlordibenzo-p-dioxin , 2002, International archives of occupational and environmental health.

[26]  N. Kerkvliet.  Immunological effects of chlorinated dibenzo-p-dioxins. , 1995, Environmental health perspectives.

[27]  M. Salifu,et al.  The F11 receptor (F11R/JAM-A) in atherothrombosis: Overexpression of F11R in atherosclerotic plaques , 2007, Thrombosis and Haemostasis.

[28]  K. Robertson,et al.  An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis. , 2006, Cancer research.

[29]  P. Stanley,et al.  Regulation of Notch signaling during T‐ and B‐cell development by O‐fucose glycans , 2009, Immunological reviews.

[30]  C. Tohyama,et al.  Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible and -suppressive genes in the rat placenta: induction of interferon-regulated genes with possible inhibitory roles for angiogenesis in the placenta. , 2004, Endocrine journal.

[31]  I. van der Linden,et al.  Cell-type specific calcium signaling by corticotropin-releasing factor type 1 (CRF1) and 2a (CRF2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells. , 2004, Biochemical pharmacology.

[32]  E. Lamirande.  Semenogelin, the main protein of the human semen coagulum, regulates sperm function. , 2007 .

[33]  U. Smith,et al.  Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. , 2003, Obesity research.

[34]  G. Srivastava,et al.  The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas , 2007, Laboratory Investigation.

[35]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[36]  U. Jaeger,et al.  The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Nelson,et al.  PLAC1 expression increases during trophoblast differentiation: Evidence for regulatory interactions with the fibroblast growth factor‐7 (FGF‐7) axis , 2005, Molecular reproduction and development.

[38]  C Zocchetti,et al.  Health effects of dioxin exposure: a 20-year mortality study. , 2001, American journal of epidemiology.

[39]  P. Lesca,et al.  MODULATING EFFECTS OF 2,3,7,8- TETRACHLORODIBENZO-P-DIOXIN ON SKIN CARCINOGENESIS INITIATED BY THE WEAK INDUCER 7,12-DIMETHYLBENZ(A)ANTHRACENE , 1994, Drug metabolism and drug interactions.

[40]  P. Martin-DeLeon.  Epididymal SPAM1 and its impact on sperm function , 2006, Molecular and Cellular Endocrinology.

[41]  A. Baccarelli,et al.  Aryl-hydrocarbon receptor-dependent pathway and toxic effects of TCDD in humans: a population-based study in Seveso, Italy. , 2003, Toxicology letters.

[42]  M. Zakrzewska,et al.  FGF-1: From Biology Through Engineering to Potential Medical Applications , 2008 .

[43]  T. Kodama,et al.  Role of macrophage scavenger receptor in endotoxin shock , 2000, The Journal of pathology.

[44]  Christoph Wanner,et al.  Identification of a new tumor suppressor gene located at chromosome 8p21.3–22 , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  M. Laan,et al.  Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns. , 2010, The Journal of clinical endocrinology and metabolism.

[46]  A. von Haeseler,et al.  Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor , 2008, Haematologica.

[47]  C. Rose,et al.  Developmental profile and mechanisms of GABA‐induced calcium signaling in hippocampal astrocytes , 2008, Glia.

[48]  P. Comoglio,et al.  The MET receptor tyrosine kinase in invasion and metastasis , 2007, Journal of cellular physiology.

[49]  Jiayuh Lin,et al.  Stat3 upregulates MEK5 expression in human breast cancer cells , 2004, Oncogene.

[50]  B. Bogerts,et al.  Evidence for a wide extra-astrocytic distribution of S100B in human brain , 2007, BMC Neuroscience.

[51]  G. Christofori,et al.  Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. , 2006, Cancer cell.

[52]  K. Shimoya,et al.  S100B protein expression in the amnion and amniotic fluid in pregnancies complicated by pre-eclampsia. , 2006, Molecular human reproduction.

[53]  T. Kipps,et al.  Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Dower,et al.  Human Tribbles, a Protein Family Controlling Mitogen-activated Protein Kinase Cascades* , 2004, Journal of Biological Chemistry.

[55]  Kyle Steenland,et al.  Dioxin Revisited: Developments Since the 1997 IARC Classification of Dioxin as a Human Carcinogen , 2004, Environmental health perspectives.

[56]  D. Hicklin,et al.  FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells. , 2004, Blood.

[57]  N. Dillon,et al.  The λ5–VpreB1 locus—a model system for studying gene regulation during early B cell development , 2005 .

[58]  Hoguen Kim,et al.  Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations , 2006, Proteomics.

[59]  G. Shapiro,et al.  Cyclin-dependent kinase pathways as targets for cancer treatment. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  J. Hoheisel,et al.  Basic transcription factor 3 (BTF3) regulates transcription of tumor-associated genes in pancreatic cancer cells , 2007, Cancer biology & therapy.

[61]  L. Birnbaum,et al.  TCDD alters the extracellular matrix and basal lamina of the fetal mouse kidney. , 1987, Teratology.

[62]  S. Heimfeld,et al.  Comparison of gene expression in CD34+ cells from bone marrow and G-CSF-mobilized peripheral blood by high-density oligonucleotide array analysis. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[63]  Yusuke Nakamura,et al.  Methylation at CpG islands in intron 1 of EGR2 confers enhancer‐like activity , 2003, FEBS letters.

[64]  G. Martinelli,et al.  Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer , 2004, Clinical Cancer Research.

[65]  Hongyue Dai,et al.  Gene expression changes associated with progression and response in chronic myeloid leukemia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[66]  T. Kajiume,et al.  TCDD treatment eliminates the long-term reconstitution activity of hematopoietic stem cells. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[67]  J. Schmidtke,et al.  Structure and function of TSPY, the Y-chromosome gene coding for the “testis-specific protein” , 1998, Cytogenetic and Genome Research.